A Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Persistent Asthma
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 27 Sep 2017
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Acronyms Liberty Asthma Quest
- Sponsors Sanofi
- 27 Sep 2017 This trial has been completed in Spain.
- 11 Sep 2017 Results published in a Sanofi media release.
- 11 Sep 2017 Results presented in a Regeneron Pharmaceuticals media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History